Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Disarming flu viruses.

× No keyword cloud information.

12 in total

1. Development and testing of a de novo drug-design algorithm.

Authors: Eric Pellegrini; Martin J Field
Journal: J Comput Aided Mol Des Date: 2003-10 Impact factor: 3.686

Review 2. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

Authors: G He; J Massarella; P Ward
Journal: Clin Pharmacokinet Date: 1999-12 Impact factor: 6.447

3. Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir.

Authors: Michael Z Wang; Chun Y Tai; Dirk B Mendel
Journal: Antimicrob Agents Chemother Date: 2002-12 Impact factor: 5.191

4. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA).

Authors: B Herrmann; C Larsson; B W Zweygberg
Journal: J Clin Microbiol Date: 2001-01 Impact factor: 5.948

5. Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication.

Authors: Inna Karpenko; Sergey Deev; Oleg Kiselev; Valerey Charushin; Vladimir Rusinov; Eugeney Ulomsky; Ella Deeva; Dmitry Yanvarev; Alexander Ivanov; Olga Smirnova; Sergey Kochetkov; Oleg Chupakhin; Marina Kukhanova
Journal: Antimicrob Agents Chemother Date: 2010-03-01 Impact factor: 5.191

10. Guanidine modifications enhance the anti-herpes simplex virus activity of (E,E)-4,6-bis(styryl)-pyrimidine derivatives in vitro and in vivo.

Authors: Wei Wang; Cuijing Xu; Jianqiang Zhang; Jinpeng Wang; Rilei Yu; Dongping Wang; Ruijuan Yin; Wenmiao Li; Tao Jiang
Journal: Br J Pharmacol Date: 2020-01-23 Impact factor: 8.739

Disarming flu viruses.

1. Development and testing of a de novo drug-design algorithm.

Review 2. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

3. Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir.

4. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA).

5. Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication.

6. Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes.

7. Crystallizing membrane proteins using lipidic mesophases.

Review 8. The treatment of influenza with antiviral drugs.

9. Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids.

10. Guanidine modifications enhance the anti-herpes simplex virus activity of (E,E)-4,6-bis(styryl)-pyrimidine derivatives in vitro and in vivo.